Since May 2025, BirthTech and Heamac have been collaborating on data-informed algorithm development. Heamac’s work in neonatal jaundice care provides baby-weight information and existing inputs from treating doctors that BirthTech takes into consideration when improving its algorithms.
What Heamac contributes
The collaboration draws on baby-weight data and existing doctor inputs associated with neonatal jaundice treatment. These are the care inputs informing our work; we are not presenting a new treatment service through this partnership.
How BirthTech uses the inputs
BirthTech considers these inputs as it develops and improves its algorithms. They bring neonatal-care context into the development process, connecting baby information with observations already recorded by doctors.
An encrypted, two-way exchange
BirthTech receives relevant inputs from Heamac and also shares BirthTech data with Heamac. Data transfers between the organisations are encrypted.
This is an active development collaboration. It does not by itself establish diagnostic accuracy or treatment effectiveness.